| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | President &CEO
2 companies
De Witte Jan is a President &CEO at IART, with reported holdings spanning 2 companies. Recent filings cover 1 purchase and 5 sales. Those positions are worth an estimated $1.5M at current prices.
Our model assigns De Witte Jan a below-average insider score of 45/100, based on 6 past trades. Over a 12-month horizon, 25.0% of those trades were profitable, with an average 12-month return of -4.8%.
De Witte Jan's largest disclosed position is in RMD as Director, worth about $1.1M. The recent filings there lean toward selling, a net 5,698 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 25, 2025 | RMD Resmed Inc | Director | Sell10b5-1 | 2,055 | $255.00 | $524,025.00 | -32.5% | +2.0% | - | |
| Nov 11, 2025 | RMD Resmed Inc | Director | Sell10b5-1 | 487 | $250.25 | $121,871.75 | -8.4% | +9.3% | - | |
| May 20, 2025 | RMD Resmed Inc | Director | Sell10b5-1 | 2,000 | $243.47 | $486,940.00 | -25.6% | +15.3% | -15.4% | |
| Nov 12, 2024 | RMD Resmed Inc | Director | Sell10b5-1 | 796 | $248.81 | $198,052.76 | -10.6% | -3.5% | +2.3% | |
| May 15, 2024 | RMD Resmed Inc | Director | Sell | 360 | $218.29 | $78,584.40 | -4.6% | -0.2% | +12.7% | |
| Jun 1, 2023 | IART Integra Lifesciences Holdings Corp | President &CEO | Buy | 7,792 | $38.50 | $299,985.77 | +155.7% | +13.3% | -19.6% |